IRadimed Corporation IRMD · Stock Open IRadimed Corporation in new tab
IRadimed Corporation Analysis (IRMD)
Is IRadimed Corporation a good investment? IRadimed Corporation (IRMD) is currently trading at 95.08 USD. Market analysts have a consensus price target of 118.00 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 51.63. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: IRadimed Corporation is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 2.36.
For income investors, IRadimed Corporation pays a dividend yield of 1.28%. With a payout ratio of 65%, the dividend appears sustainable.
Investor FAQ
Does IRadimed Corporation pay a dividend?
Yes, it pays an annual dividend of 1.24 USD (1.28% yield).
What asset class is IRadimed Corporation?
IRadimed Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 1.83.
Company Profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.40 USD
|
| May 31, 2027 (estimated) | 0.2000 |
| March 8, 2027 (estimated) | 0.2000 |
| ▸2026 |
1.24 USD
|
| Dec. 30, 2026 (estimated) | 0.5000 |
| Nov. 25, 2026 (estimated) | 0.1700 |
| Aug. 31, 2026 (estimated) | 0.1700 |
| May 29, 2026 | 0.2000 |
| March 6, 2026 | 0.2000 |
| ▸2025 |
1.18 USD
|
| Dec. 30, 2025 | 0.5000 |
| Nov. 25, 2025 | 0.1700 |
| Aug. 28, 2025 | 0.1700 |
| May 30, 2025 | 0.1700 |
| March 5, 2025 | 0.1700 |
| ▸2024 |
1.08 USD
|
| Nov. 25, 2024 | 0.1500 |
| Aug. 30, 2024 | 0.1500 |
| May 30, 2024 | 0.1500 |
| Jan. 12, 2024 | 0.6300 |
| ▸2023 |
1.05 USD
|
| Feb. 21, 2023 | 1.0500 |
| ▸2022 |
1.00 USD
|
| Feb. 24, 2022 | 1.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| IRadimed Corporation | May 29, 2026 | Paid | 0.2 USD |
| IRadimed Corporation | Mar 06, 2026 | Paid | 0.2 USD |
| IRadimed Corporation | Dec 30, 2025 | Paid | 0.5 USD |
| IRadimed Corporation | Nov 25, 2025 | Paid | 0.17 USD |
| IRadimed Corporation | Aug 28, 2025 | Paid | 0.17 USD |
Community Discussion